Page last updated: 2024-09-05

erlotinib hydrochloride and nsc 23766

erlotinib hydrochloride has been researched along with nsc 23766 in 2 studies

Compound Research Comparison

Studies (erlotinib hydrochloride)	Trials (erlotinib hydrochloride)	Recent Studies (post-2010) (erlotinib hydrochloride)	Studies (nsc 23766)	Trials (nsc 23766)	Recent Studies (post-2010) (nsc 23766)
4,353	786	3,033	200	0	147

Protein Interaction Comparison

Protein	Taxonomy	erlotinib hydrochloride (IC50)	nsc 23766 (IC50)
Ras-related C3 botulinum toxin substrate 1	Mus musculus (house mouse)		6.3

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bachem, MG; Debatin, KM; Dwucet, A; Halatsch, ME; Karpel-Massler, G; Kast, RE; Nonnenmacher, L; Westhoff, MA; Wirtz, CR; Zhou, S	1
Debatin, KM; Dwucet, A; Halatsch, ME; Karpel-Massler, G; Karpel-Massler, S; Kast, RE; Nonnenmacher, L; Siegelin, MD; Westhoff, MA; Wirtz, CR	1

Other Studies

2 other study(ies) available for erlotinib hydrochloride and nsc 23766

Article	Year
Combined inhibition of HER1/EGFR and RAC1 results in a synergistic antiproliferative effect on established and primary cultured human glioblastoma cells. Molecular cancer therapeutics, 2013, Volume: 12, Issue:9 Topics: Aminoquinolines; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Male; Mice, Inbred NOD; Molecular Targeted Therapy; Pyrimidines; Quinazolines; rac1 GTP-Binding Protein; Signal Transduction; Xenograft Model Antitumor Assays	2013
Simultaneous Interference with HER1/EGFR and RAC1 Signaling Drives Cytostasis and Suppression of Survivin in Human Glioma Cells in Vitro. Neurochemical research, 2017, Volume: 42, Issue:5 Topics: Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cytostatic Agents; ErbB Receptors; Erlotinib Hydrochloride; Glioma; Humans; Inhibitor of Apoptosis Proteins; Pyrimidines; rac1 GTP-Binding Protein; Signal Transduction; Survivin	2017

Article

Year

Combined inhibition of HER1/EGFR and RAC1 results in a synergistic antiproliferative effect on established and primary cultured human glioblastoma cells.

Molecular cancer therapeutics, 2013, Volume: 12, Issue:9

Topics: Aminoquinolines; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Male; Mice, Inbred NOD; Molecular Targeted Therapy; Pyrimidines; Quinazolines; rac1 GTP-Binding Protein; Signal Transduction; Xenograft Model Antitumor Assays

2013

Simultaneous Interference with HER1/EGFR and RAC1 Signaling Drives Cytostasis and Suppression of Survivin in Human Glioma Cells in Vitro.

Neurochemical research, 2017, Volume: 42, Issue:5

Topics: Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cytostatic Agents; ErbB Receptors; Erlotinib Hydrochloride; Glioma; Humans; Inhibitor of Apoptosis Proteins; Pyrimidines; rac1 GTP-Binding Protein; Signal Transduction; Survivin

2017